Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
SilvaSorb Site ® Ionic silver percutaneous site protection. The difference is clear. A A dressing dressing that that helps helps fight fight infection infection at at port & catheter sites. pin,pin, port & catheter sites. SilvaSorb® Site dressings can help reduce the risk of infection at I.V. insertion sites and other indwelling percutaneous devices. Advanced technology provides controlled, sustained-release of antimicrobial ionic silver, killing infection-causing bacteria, yeast and fungi for up to seven days without harming tissue cells. SilvaSorb dressings have been shown to reduce bacterial counts by 99.99% within 2 hours (data on file), even on intact skin as silver release is induced by moisture transpired by the skin. Infection statistics: According to the Centers for Disease Control and Prevention (CDC), an estimated 250,000 cases of bloodstream infections associated with central venous catheters occur each year in U.S. hospitals. SilvaSorb is fast acting. These infections add approximately $25,000 in patient care costs per episode. And, the mortality associated with these infections is 18% or 45,000 deaths per year. (CDC, Guidelines for the Prevention of Intravascular Catheter-Related Infections, Recommendations and Reports, Morbidity and Mortality Weekly Report, August 9, 2002,Vol. 51, No. RR-10) 1 A snug fit means less room for bacteria to enter Gap The SilvaSorb Site dressing is available in two sizes.The one-inch circular pad with a 4-mm center saddle and a radial slit allows full contact between the dressing and the indwelling device, with little to no gap where bacteria could easily enter.The 1.75” circular pad with starburst and radial slit accommodates larger devices such as ports, gastrostomy tubes Gap or large bore needles. Partial contact vs. complete coverage Gap While other site dressings may leave gaps that can serve as potential entry points for bacteria, the SilvaSorb Site is designed to reduce this vulnerability. No Gap No Gap Gap Competitive Device SilvaSorb Site No Gap Important features and benefits of SilvaSorb Site dressings No Gap Feature Benefit Sustained release of ionic silver Broad-spectrum antimicrobial protection for up to 7 days1,7 Self-activating, self-regulating Requires no wetting or re-wetting to activate,2 reduces skin bioburden without wetting Full-contact saddle & starburst design Eliminates gaps; helps keep bacteria out Thin, flexible material Lies flat for a comfortable, secure fit Translucent Easy to monitor insertion site Non-staining No discoloration of site to interfere with assessment Super-absorbent, polyacrylate Maintains optimal moisture balance 1 Non-adherent Pain-free removal Non-toxic, non-irritating, non-sensitizing Improved patient safety and comfort 1 Contains no CHG Less chance for irritation How do SilvaSorb Site dressings compare to other insertion site dressings? Antimicrobial ingredients. SilvaSorb Site utilizes ionic silver, a proven antimicrobial agent7 that is non-irritating. Some dressings use chlorhexidine gluconate (CHG) to kill bacteria.This is a common antiseptic that can cause hypersensitivity reactions and has not been proven safe for use on children.3,4,5 Material. SilvaSorb Site dressing is made of a thin, flexible, translucent, hydrophilic material that allows for visualization and monitoring of the insertion site. It lies flat and conforms to the site for greater comfort and a secure fit. By contrast, other dressings are made of thick, opaque foam that are bulky and do not allow site monitoring. Design. SilvaSorb Site dressings have a unique “saddle design” that provides complete contact at the insertion site. The physical design combined with the antimicrobial activity reduces the risk of bacteria migrating into the site. Other insertion site dressings have a simple hole in the middle, which can create a gap between the dressing and the catheter or other device. Where can I use SilvaSorb Site dressings? Use SilvaSorb Site dressings with the following devices: Vascular devices • I.V. catheters • Peripheral catheters • PICC lines • Central venous (CV) lines • Arterial catheters • Dialysis catheters • Other indwelling catheters Non-vascular percutaneous devices • Peritoneal dialysis catheters • Epidural catheters • Chest tubes • Gastrostomy feeding tubes • External fixator pins Use Sureview I.V. dressings to cover and secure your SilvaSorb Site dressing. Clinical use of SilvaSorb Site Use on burn and pediatric patients: • Dressing use on 47 adult burn patients proved ease of use, cost-effectiveness, and prevention of local or Catheter Related Bloodstream Infection (CRBSI) in all patients.6 • Site dressing use on 14 pediatric patients showed ease of use, lack of local reactions, and zero incidence of local or systemic infection.8 Ordering information Item No. Description HCPCS Pkg. MSC9310EP 1" disc with 4-mm center saddle and radial slit A6242 30/cs A6242 30/cs For larger devices (5-13 mm) such as gastric feeding tubes: MSC9320EP 13/4" disc with center hole How easy is it to use? Application is quick and simple: • Wrap dressing around insertion site • Overlap the sides around the insertion device or catheter hub • Cover and secure with transparent film (such as Sureview™ I.V. dressings) • Remove every 7 days (more often if heavy exudate is present) 1” Disc (actual size) 1 3/4” Disc (actual size) Gentle effectiveness within a reasonable time Candida albicans 2 4.27 0 0 2.27 E. coli Quantitative using4 the AATCC-100 4 6 recovery 8 measurements on microorganisms 2 6 8 method shows that SilvaSorb Site 4.26 4.2 4.29 Control 6.2 6.15 5.98 6.2 demonstrates similar effectiveness (log reduction) as the CHG containing site dressing within hours of contact with 0 0 0 Biopatch 0 0 0 0 7 the test microorganisms.This performance is also similar or better than 1.6 0 0 Silver Site 0 0 0 the other 0 silver-based site during testing. 1.39 0 0 SilvaSorb Site 0 0 Candida albicans 0 0 E. coli Candida albicans E. coli 5 7 6 Control Biopatch Silver Site SilvaSorb Site Log10 3 2 1 0 aecalis (Vancomycin Resistant) -1 2 5.09 0 4.89 4.5 4 5.14 0 4.54 2.48 62 5.1 0 4.23 0 Pseudomonas 4 8 5.19 Hours 0 4.04 0 6 8 Control Biopatch Silver Site SilvaSorb Site 2 5.74 0 0 0 Log10 4 5 4 3 2 1 0 aeruginosa -1 Entercoccus faecalis (Vancomycin resistent) 4 5.69 0 0 0 Control Biopatch Silver Site SilvaSorb Site 62 4.6 0 0 0 7 6 Log10 4 Control Biopatch Silver Site SilvaSorb Site 3 2 1 0 62 6.27 0 0 0 4 8 6.4 Hours 0 0 0 6 Log10 5 4 6.41 0 3.87 0 * Biopatch, Silver Site and SilvaSorb Site all register at “0” Pseudomonas aeruginosa 6 5 4 3 2 Control Biopatch Silver Site SilvaSorb Site 1 0 -1 8 2 4 6 8 Hours* * Biopatch, Silver Site and SilvaSorb Site all register at “0” References Staphylococcus aureus 1. Internal Report on File. 2. Skin Bioburden Reduction Test, Acryderm Silver Antimicrobial Dressing. Technical Report 01/138, 2001. Staphylococcus aureus 3. Garland JS, Alex CP, Mueller CD, Otten D, Shivpui C, Harris MC, Naples M, Pellegrini J, Buck RK, McAuliffe TL, Goldmann DA, Maki DG. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics. 2001; 107(6): 1431-1436. 7 6 Log10 2 6.2 0 5.18 5.14 8 Pseudomonas aeruginosa Entercoccus faecalis (Vancomycin Resistant) phylococcus aureus -1 4 8 6 4.42 Hours* 0 0 0 5 4 3 2 Control Biopatch Silver Site SilvaSorb Site 1 0 -1 4. Garland JS, Alex CP, Mueller CD, Cisier-Kahill LA. Local reactions to a chlorhexidine gluconate-impregnated antimicrobial dressing in very low birth weight infants. Pediatric Infectious Disease Journal. 1996; 15(109): 912-914. 5. FDA” U.S. Food and Drug Administration.The Public Health Notifications page. Available at: http://www.fda.gov/cdrh/chlorhex.heml. Accessed November 13, 2007. 6. Wilson J, Friedman B, et al. An evaluation of the new SilvaSorb Site dressing for use in adult burn patients.The Joseph M Still Research Foundation, Augusta, GA, 2006. 2 4 6 8 Hours 7. Internal Report, AATCC 100 testing, Report #648/10R, 2006. 8. Copty T, Kiran RV, Glat P. Assessing the risk of skin irritation with the use of a silver based site dressing on pediatric patients. Symposium on Advanced Wound Care. San Antonio. 2006. To learn more about SilvaSorb antimicrobial dressings, including SilvaSorb Sheets, SilvaSorb Cavity, and SilvaSorb Gel, ask your Medline representative for a copy of our full-line brochure. Or, visit our website: www.medline.com/woundcare Targeted antimicrobial protection 1-800-MEDLINE | www.medline.com ©2008 Medline Industries, Inc. One Medline Place, Mundelein, IL 60060 Medline is a registered trademark of Medline Industries, Inc. SilvaSorb and MicroLattice are trademarks of AcryMed, Inc. MKT207330 / LIT145 / 3ZPN / 10M